NRx Pharmaceuticals, Inc. (NRXPW)
NRXPW Stock Price Chart
Explore NRx Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze NRXPW price movements and trends.
NRXPW Company Profile
Discover essential business fundamentals and corporate details for NRx Pharmaceuticals, Inc. (NRXPW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Dec 2017
Employees
—
Website
https://www.nrxpharma.comCEO
Jonathan C. Javitt
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
NRXPW Financial Timeline
Browse a chronological timeline of NRx Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 15 May 2025
EPS came in at -$0.52 falling short of the estimated -$0.28 by -84.98%, while revenue for the quarter reached $1.14M .
Earnings released on 30 Jun 2023
EPS came in at -$0.00 .
Earnings released on 31 Mar 2023
EPS came in at -$0.19 .
Earnings released on 31 Dec 2022
EPS came in at -$0.09 .
NRXPW Stock Performance
Access detailed NRXPW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.